Companies:
49,811
Total Market Cap:
139346455869686.86
Global Rank
#2491
Country Rank
#330
Market Cap
7.36 B
Price
2.36
Change (%)
0.22%
Volume
4.09 M
Sinopharm Group Co. Ltd.'s latest marketcap:
7.36 B
As of 07/05/2025, Sinopharm Group Co. Ltd.'s market capitalization has reached $7.36 B. According to our data, Sinopharm Group Co. Ltd. is the 2491th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 7.36 B |
| Revenue (ttm) | 79.04 B |
| Net Income (ttm) | 967.52 M |
| Shares Out | 3.12 B |
| EPS (ttm) | 0.31 |
| Forward PE | 6.76 |
| Ex-Dividend Date | 06/16/2025 |
| Earnings Date | 08/28/2025 |
Market Cap Chart
Data Updated: 07/05/2025
Sinopharm Group Co. Ltd.'s yearly market capitalization.
Sinopharm Group Co. Ltd. has seen its market value drop from HK$75.96 B to HK$7.36 B since 2014, representing a total decrease of 90.31% and an annual compound decline rate (CAGR) of 19.91%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | HK$7.36 B | -13.15% | 2491 |
| 12/31/2024 | HK$66.47 B | 4.16% | 1964 |
| 12/29/2023 | HK$63.82 B | 3.07% | 1931 |
| 12/30/2022 | HK$61.91 B | 16.98% | 1822 |
| 12/31/2021 | HK$52.93 B | -10.07% | 2504 |
| 12/31/2020 | HK$58.86 B | -30.29% | 2030 |
| 12/31/2019 | HK$84.43 B | -13.46% | 1234 |
| 12/31/2018 | HK$97.57 B | 4.57% | 899 |
| 12/29/2017 | HK$93.31 B | 5.54% | 1095 |
| 12/30/2016 | HK$88.41 B | 2.73% | 898 |
Company Profile
About Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd., together with its subsidiaries, operates in the wholesale and retail of pharmaceutical and medical devices, as well as healthcare products in China. Headquartered in Shanghai, the company was founded in 2003 and is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Business Segments
- Pharmaceutical Distribution: Distributes pharmaceutical products to hospitals, clinics, and retail pharmacies. Provides logistics and value-added services for domestic and international manufacturers.
- Medical Devices: Specializes in the distribution of medical equipment and devices.
- Retail Pharmacy: Operates and franchises a network of retail drug stores.
- Other Business: Engages in pharmaceutical production, chemical reagents, laboratory supplies, property management, and various consulting services.
Additional Operations
The company also offers:
- Medical instruments and Chinese herbal medicine distribution.
- IT services, investment, and import/export operations.
- Health, medical, and market consulting services.
- Medical project investment and technology training.
Frequently Asked Questions
-
What is Sinopharm Group Co. Ltd.'s (HKG-1099) current market cap?As of 07/05/2025, Sinopharm Group Co. Ltd. (including the parent company, if applicable) has an estimated market capitalization of $7.36 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sinopharm Group Co. Ltd. (HKG-1099) rank globally by market cap?Sinopharm Group Co. Ltd. global market capitalization ranking is approximately 2491 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.